Here are five facts:
1. Sales are up 41 percent.
2. Revenue in the United States increased 52 percent.
3. In the first half of 2015, 3,716 PediGuard units were sold, compared to 3,008 units in the first half of 2014.
4. Gross margin of 86.1 percent is up from last year’s 85.6 percent.
5. The company’s net loss was reduced.
More articles on devices:
Conventus Orthopaedics’ promixal radius system receives FDA approval: 4 takeaways
4 key notes on Histogenics & Collagen Solutions’ supply agreement
Life Spine receives 100th patent: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
